Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281745128> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- W4281745128 abstract "Introduction: Therapeutic inertia is a major contributor to people with diabetes not achieving glycemic goals. We assessed for patients with T2D the impact of using the FreeStyle Libre system (FSL) vs. blood glucose monitoring (BGM) on treatment intensification. Method: We carried out a matched retrospective cohort study using secondary private payer claims data including >30 million diabetes drug and device claims filled by over 850,000 patients with T2D >18 in Canada over 24 months. Each month, patients were classified by level of therapy progression: 1. No diabetes drug therapy; 2. Mono Oral Antihyperglycemic Agents (OHAs) ; 3. Dual OHAs; 4. Triple OHAs; 5. Quad or more OHAs; 6. Injectable GLP1-RA (±concomitant OHAs) ; 7. Basal insulin (±concomitant OHAs) ; 8. MDI insulin (±concomitant OHAs) . Results: A total of 373,871 patients met the inclusion criteria. Across all treatment cohorts, the FSL treatment groups were found to have a statistically higher probability of treatment intensification relative to BGM: Conclusion: Reimbursement of FSL for patients with T2D in Canada is associated with decreased time lag for glucose lowering therapy compared to those using BGM alone. These findings suggest that FSL data impact clinicians to facilitate earlier and more intensive therapy modifications and thus reduce treatment inertia. Disclosure S.B.Harris: Consultant; Abbott, AstraZeneca, Eli Lilly and Company, Novo Nordisk, Sanofi, Other Relationship; Abbott, AstraZeneca, Bayer Inc., Dexcom, Eli Lilly and Company, HLS Therapeutics, Janssen Pharmaceuticals, Inc., Novo Nordisk, Sanofi, Research Support; Applied Therapeutics Inc., AstraZeneca, Canadian Institutes of Health Research, Juvenile Diabetes Research Foundation (JDRF) , Novo Nordisk, Sanofi, The Lawson Foundation. F.Levrat-guillen: Employee; Abbott. Funding Funded by Abbott Diabetes Care" @default.
- W4281745128 created "2022-06-13" @default.
- W4281745128 creator A5038040018 @default.
- W4281745128 creator A5042466344 @default.
- W4281745128 date "2022-06-01" @default.
- W4281745128 modified "2023-09-25" @default.
- W4281745128 title "680-P: Effect of the FreeStyle Libre System on Diabetes Treatment for People with T2D: Results from a Retrospective Cohort Study Using Canadian Private Payer Claims Database" @default.
- W4281745128 doi "https://doi.org/10.2337/db22-680-p" @default.
- W4281745128 hasPublicationYear "2022" @default.
- W4281745128 type Work @default.
- W4281745128 citedByCount "0" @default.
- W4281745128 crossrefType "journal-article" @default.
- W4281745128 hasAuthorship W4281745128A5038040018 @default.
- W4281745128 hasAuthorship W4281745128A5042466344 @default.
- W4281745128 hasConcept C126322002 @default.
- W4281745128 hasConcept C134018914 @default.
- W4281745128 hasConcept C160735492 @default.
- W4281745128 hasConcept C162324750 @default.
- W4281745128 hasConcept C167135981 @default.
- W4281745128 hasConcept C2777180221 @default.
- W4281745128 hasConcept C2779306644 @default.
- W4281745128 hasConcept C2779384505 @default.
- W4281745128 hasConcept C2779703844 @default.
- W4281745128 hasConcept C2780473172 @default.
- W4281745128 hasConcept C50522688 @default.
- W4281745128 hasConcept C555293320 @default.
- W4281745128 hasConcept C71924100 @default.
- W4281745128 hasConcept C72563966 @default.
- W4281745128 hasConceptScore W4281745128C126322002 @default.
- W4281745128 hasConceptScore W4281745128C134018914 @default.
- W4281745128 hasConceptScore W4281745128C160735492 @default.
- W4281745128 hasConceptScore W4281745128C162324750 @default.
- W4281745128 hasConceptScore W4281745128C167135981 @default.
- W4281745128 hasConceptScore W4281745128C2777180221 @default.
- W4281745128 hasConceptScore W4281745128C2779306644 @default.
- W4281745128 hasConceptScore W4281745128C2779384505 @default.
- W4281745128 hasConceptScore W4281745128C2779703844 @default.
- W4281745128 hasConceptScore W4281745128C2780473172 @default.
- W4281745128 hasConceptScore W4281745128C50522688 @default.
- W4281745128 hasConceptScore W4281745128C555293320 @default.
- W4281745128 hasConceptScore W4281745128C71924100 @default.
- W4281745128 hasConceptScore W4281745128C72563966 @default.
- W4281745128 hasIssue "Supplement_1" @default.
- W4281745128 hasLocation W42817451281 @default.
- W4281745128 hasOpenAccess W4281745128 @default.
- W4281745128 hasPrimaryLocation W42817451281 @default.
- W4281745128 hasRelatedWork W2015295066 @default.
- W4281745128 hasRelatedWork W2066909715 @default.
- W4281745128 hasRelatedWork W2325885830 @default.
- W4281745128 hasRelatedWork W2415759662 @default.
- W4281745128 hasRelatedWork W2510681507 @default.
- W4281745128 hasRelatedWork W2549358428 @default.
- W4281745128 hasRelatedWork W2911358446 @default.
- W4281745128 hasRelatedWork W3090938678 @default.
- W4281745128 hasRelatedWork W4206946711 @default.
- W4281745128 hasRelatedWork W4248781434 @default.
- W4281745128 hasVolume "71" @default.
- W4281745128 isParatext "false" @default.
- W4281745128 isRetracted "false" @default.
- W4281745128 workType "article" @default.